Apnimed

Cambridge, United States

Apnimed is a clinical-stage company dedicated to the discovery of novel pharmacologic therapies for sleep apnea and related disorders.

$16.5M raised

Apr 2026

Debt Financing

Top Investors

Alpha Wave GlobalHealthCare Royalty PartnersTao Capital PartnersMorningsideAlpha Wave Ventures

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Apnimed raised?

Apnimed has raised $16.5M in total funding. The most recent round was Debt Financing. The last funding was announced in April 2026.

Who are Apnimed's investors?

Apnimed's investors include Alpha Wave Global, HealthCare Royalty Partners, Tao Capital Partners, Morningside, Alpha Wave Ventures.

Where is Apnimed headquartered?

Apnimed is headquartered in Cambridge, United States.

What does Apnimed do?

Apnimed is a clinical-stage company dedicated to the discovery of novel pharmacologic therapies for sleep apnea and related disorders.

What stage is Apnimed at?

Apnimed is at the Debt Financing stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 6, 2026.

MLA

"Apnimed — Funding & Investors." VCBacked, April 6, 2026, https://www.vcbacked.co/company/apnimed. Accessed June 3, 2026.

APA

VCBacked. (2026). Apnimed — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/apnimed

Wikipedia (cite web)

{{cite web |title=Apnimed — Funding & Investors |url=https://www.vcbacked.co/company/apnimed |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 6, 2026.